FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin |
Liang, Tao
(Department of Urology, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences)
Ye, Xuxiao (Department of Urology, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences) Liu, Yuanyuan (Department of Urology, Affiliated Hospital of Binzhou Medical University) Qiu, Xinkai (Department of Urology, Affiliated Hospital of Binzhou Medical University) Li, Zuowei (Department of Urology, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences) Tian, Binqiang (Department of Urology, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences) Yan, Dongliang (Department of Urology, Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences) |
1 | Center, M. M. et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 61, 1079-1092 (2012). DOI |
2 | Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7-30 (2016). DOI |
3 | Wen, S., Niu, Y., Lee, S. O. & Chang, C. Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death. Cancer Treat. Rev. 40, 31-40 (2014). DOI |
4 | Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87-108 (2015). DOI |
5 | Ozdemir, T. R. et al. Whole-genome gene expression analysis in urine samples of patients with prostate cancer and benign prostate hyperplasia. Urol. Oncol. 35, 607.e15-607.e24 (2017). DOI |
6 | Etokebe, G. E. et al. Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations. PLoS ONE 10, e0122651 (2015). DOI |
7 | Deng, Z. et al. Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population. J. Hum. Genet 61, 1027-1034 (2016). DOI |
8 | Zhang, Q. Y., Yue, X.Q., Jiang, Y. P., Han, T. & Xin, H. L. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells. Sci. Rep. 7, 396 (2017). DOI |
9 | Mroczek, S. et al. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. Nat. Commun. 8, 619 v (2017). DOI |
10 | Zhu, Y. X. et al. Loss of FAM46C promotes cell survival in myeloma. Cancer Res. 77, 4317-4327 (2017). DOI |
11 | Faramarzi, S. & Ghafouri-Fard, S. Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy. Immunotherapy 9, 1019-1034 (2017). DOI |
12 | Zhao, Y. et al. MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing beta-catenin nuclear accumulation. Oncol. Rep. 38, 3055-3063 (2017). DOI |
13 | Kuehl, W. M. & Bergsagel, P. L. Molecular pathogenesis of multiple myeloma and its premalignant precursor. J. Clin. Invest. 122, 3456-3463 (2012). DOI |
14 | Benjachat, T. et al. Biomarkers for refractory lupus nephritis: a microarray study of kidney tissue. Int J. Mol. Sci. 16, 14276-14290 (2015). DOI |
15 | Chen, Y. & Song, W. Wnt/catenin beta1/microRNA 183 predicts recurrence and prognosis of patients with colorectal cancer. Oncol. Lett. 15, 4451-4456 (2018). |
16 | Wan, X. Y. et al. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression. Am. J. Transl. Res. 9, 155-166 (2017). |
17 | Li, Y. H. et al. Mefloquine targets beta-catenin pathway and thus can play a role in the treatment of liver cancer. Microb. Pathog. 118, 357-360 (2018). DOI |
18 | Yang, Y. et al. Downregulation of miR-3127-5p promotes epithelialmesenchymal transition via FZD4 regulation of Wnt/beta-catenin signaling in non-small-cell lung cancer. Mol. Carcinog. 57, 842-853 (2018). DOI |
19 | Clevers, H. & Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205 (2012). DOI |
20 | Zhang, J. Q. et al. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/betacatenin signaling pathway by targeting CUL4B in pancreatic cancer cells. J. Cell Biochem 119, 1027-1040 (2018). DOI |
21 | Jamieson, C., Sharma, M. & Henderson, B. R. Wnt signaling from membrane to nucleus: beta-catenin caught in a loop. Int J. Biochem Cell Biol. 44, 847-850 (2012). DOI |
22 | Liu, H. et al. CSN5 promotes hepatocellular carcinoma progression by SCARA5 inhibition through Suppressing beta-catenin ubiquitination. Dig. Dis. Sci. 63, 155-165 (2018). DOI |
23 | Novellasdemunt, L. et al. USP7 is a tumor-specific WNT activator for APCmutated colorectal cancer by mediating beta-catenin deubiquitination. Cell Rep. 21, 612-627 (2017). DOI |
24 | Higashimori, A. et al. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-beta-catenin signaling axis. Cancer Res. 78, 1643-1656 (2018). DOI |
25 | Cordonnier, T. et al. Hsp27 regulates EGF/beta-catenin mediated epithelial to mesenchymal transition in prostate cancer. Int J. Cancer 136, E496-E507 (2015). DOI |
26 | Xu, X. et al. Expression of a novel gene FAM43B repressing cell proliferation is regulated by DNA methylation in hepatocellular carcinoma cell lines. Mol. Cell Biochem. 354, 11-20 (2011). DOI |
27 | Xie, H. et al. Adenovirus vector-mediated FAM176A overexpression induces cell death in human H1299 non-small cell lung cancer cells. BMB Rep. 47, 104-109 (2014). DOI |
28 | Miliani de Marval, P. L. et al. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol. Cell Biol. 24, 7538-7547 (2004). DOI |
29 | Bertoli, C., Skotheim, J. M. & de Bruin, R. A. Control of cell cycle transcription during G1 and S phases. Nat. Rev. Mol. Cell Biol. 14, 518-528 (2013). DOI |
30 | Pascual, A. & Aranda, A. Thyroid hormone receptors, cell growth and differentiation. Biochim. Biophys. Acta 1830, 3908-3916 (2013). DOI |
31 | Gordan, J. D., Bertout, J. A., Hu, C. J., Diehl, J. A. & Simon, M. C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11, 335-347 (2007). DOI |
32 | Chu, I. et al. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 128, 281-294 (2007). DOI |
33 | Yin, H. et al. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7. Oncol. Rep. 37, 1045-1051 (2017). DOI |
34 | Mahoney, S., Arfuso, F., Millward, M. & Dharmarajan, A. The effects of phenoxodiol on the cell cycle of prostate cancer cell lines. Cancer Cell Int. 14, 110 (2014). DOI |
35 | Martino, T. et al. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression. Bioorg. Med. Chem. 22, 3115-3122 (2014). DOI |
36 | Wang, D., Lu, G., Shao, Y. & Xu, D. MiR-182 promotes prostate cancer progression through activating Wnt/beta-catenin signal pathway. Biomed. Pharmacother. 99, 334-339 (2018). DOI |
37 | Rubin, S. M. Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem. Sci. 38, 12-19 (2013). DOI |
38 | Gough, N. R. Focus issue: Wnt and beta-catenin signaling in development and disease. Sci. Signal. 5, eg2 (2012). |